Ouabain, Na(+)-free and K(+)-free solutions and relaxations to nitric oxide and nitrovasodilators
- PMID: 1647345
- DOI: 10.1016/0306-3623(91)90460-n
Ouabain, Na(+)-free and K(+)-free solutions and relaxations to nitric oxide and nitrovasodilators
Abstract
1. Experiments were designed to determine the effect of inhibition of Na+, K+ ATPase by ouabain, Na(+)-free and K(+)-free solutions on the relaxations induced by nitric oxide, nitroglycerin and sodium nitroprusside in coronary smooth muscle. 2. Rings without endothelium of canine left anterior descending coronary artery were suspended for isometric tension recording in modified Krebs-Ringer bicarbonate solution, in the presence of indomethacin, propranolol, and phenoxybenzamine. The rings were incubated with ouabain, Na(+)-free or K(+)-free solutions prior to contractions with prostaglandin F2 alpha. 3. Nitric oxide induced transient relaxations which were significantly depressed by ouabain but were not affected by Na(+)- or K(+)-free solutions. Thus, the inhibitory effect of ouabain on relaxations to nitric oxide is not due to inhibition of the Na+, K+ pump. 4. The relaxation induced by sodium nitroprusside was impaired both in the presence of ouabain and after incubation in Na(+)- or K(+)-free solution, suggesting that it may involve in part activation of Na+, K+ pumping. 5. Only high concentration of ouabain and Na(+)-free solution decreased the relaxation evoked by nitroglycerin, indicating that the mechanism of action of nitroglycerin on vascular smooth muscle does not involve the Na(+)-K+ pump.
Similar articles
-
KATP-channel-induced vasodilation is modulated by the Na,K-pump activity in rabbit coronary small arteries.Br J Pharmacol. 2004 Dec;143(7):872-80. doi: 10.1038/sj.bjp.0706016. Epub 2004 Oct 25. Br J Pharmacol. 2004. PMID: 15504751 Free PMC article.
-
Ouabain inhibits endothelium-dependent relaxations to arachidonic acid in canine coronary arteries.J Pharmacol Exp Ther. 1985 Oct;235(1):81-6. J Pharmacol Exp Ther. 1985. PMID: 3930700
-
Possible role of Na(+)-K(+)-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide.Br J Pharmacol. 1995 Oct;116(4):2201-6. doi: 10.1111/j.1476-5381.1995.tb15054.x. Br J Pharmacol. 1995. PMID: 8564249 Free PMC article.
-
Nitric oxide and related vasodilators.Can J Anaesth. 1997 May;44(5 Pt 2):R23-33. doi: 10.1007/BF03022262. Can J Anaesth. 1997. PMID: 9196837 Review. English, French. No abstract available.
-
Regulation of vascular smooth muscle contraction by extracellular Na+.Gen Pharmacol. 1993 May;24(3):531-7. doi: 10.1016/0306-3623(93)90209-g. Gen Pharmacol. 1993. PMID: 8365636 Review.
Cited by
-
Endogenous Na+, K+-ATPase inhibitors and CSF [Na+] contribute to migraine formation.PLoS One. 2019 Jun 7;14(6):e0218041. doi: 10.1371/journal.pone.0218041. eCollection 2019. PLoS One. 2019. PMID: 31173612 Free PMC article.
-
The Na-K-ATPase is a target for an EDHF displaying characteristics similar to potassium ions in the porcine renal interlobar artery.Br J Pharmacol. 2002 Nov;137(5):647-54. doi: 10.1038/sj.bjp.0704919. Br J Pharmacol. 2002. PMID: 12381678 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous